SCHEMBL22207153

SCHEMBL22207153

Cn1c(N)c(Cl)ccc1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRPF1 P55201 3/20 0.41
CA12 O43570 1/20 0.38
BRD4 O60885 1/20 0.38
CA9 Q16790 1/20 0.38
KAT2B Q92831 1/20 0.38
BRD9 Q9H8M2 1/20 0.38
HTT P42858 2/20 0.35
BRD1 O95696 1/20 0.34
ALDH1A1 P00352 4/20 0.33
ALOX15 P16050 1/20 0.33
ATM Q13315 1/20 0.33
HPGD P15428 3/20 0.33
CYP3A4 P08684 2/20 0.33
SIRT2 Q8IXJ6 1/20 0.33
PRMT5 O14744 1/20 0.32
KDM4E B2RXH2 2/20 0.32
CYP1A2 P05177 1/20 0.31
BLM P54132 1/20 0.31
HSD17B10 Q99714 1/20 0.31
KMT2A Q03164 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22224593 0.74 BRPF1 (0.39) BRPF1CA12BRD4CA9KAT2B
SCHEMBL31667532 0.73 BRPF1 (0.38) BRPF1CA12BRD4CA9KAT2B
SCHEMBL22224637 0.70 BRPF1 (0.35) BRPF1CA12BRD4CA9KAT2B
SCHEMBL31666972 0.70 SMN1; SMN2 (0.36) BRPF1CA12BRD4CA9KAT2B
SCHEMBL22207243 0.68 DPP4 (0.36) BRPF1CA12BRD4CA9KAT2B
SCHEMBL31667098 0.68 BRPF1 (0.34) BRPF1CA12BRD4CA9KAT2B
SCHEMBL25075240 0.65 BRPF1 (0.39) BRPF1CA12BRD4CA9KAT2B
SCHEMBL3606061 0.65 BRPF1 (0.42) BRPF1CA12BRD4CA9KAT2B
SCHEMBL22312066 0.65 ALDH1A1 (0.40) CA12CA9HTTALDH1A1HPGD
SCHEMBL13560811 0.64 BRPF1 (0.58) BRPF1CA12BRD4CA9KAT2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3908579-B1 DIHYDROOROTATE DEHYDROGENASE INHIBITORS JANSSEN BIOTECH INC (US) 2023-12-27 EP disclosed
US-20220089568-A1 DIHYDROOROTATE DEHYDROGENASE INHIBITORS JANSSEN BIOTECH, INC. 2022-03-24 US disclosed
EP-3908579-A1 DIHYDROOROTATE DEHYDROGENASE INHIBITORS Janssen Biotech, Inc. (US) 2021-11-17 EP disclosed
WO-2020144638-A1 DIHYDROOROTATE DEHYDROGENASE INHIBITORS JANSSEN BIOTECH, INC. (US) 2020-07-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220089568-A1 DIHYDROOROTATE DEHYDROGENASE INHIBITORS DHODH, DLD, DPYD BRPF1 4042/4885CA12 3956/4885BRD4 3443/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.